U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Ovarian serous surface papillary adenocarcinoma

MedGen UID:
233279
•Concept ID:
C1335178
•
Neoplastic Process
Synonyms: Ovarian Serous Surface Papillary Adenocarcinoma; ovarian serous surface papillary adenocarcinoma; ovary papillary carcinoma; Serous Surface Papillary Carcinoma of Ovary; serous surface papillary carcinoma of ovary; Serous Surface Papillary Carcinoma of the Ovary; serous surface papillary carcinoma of the ovary
 
Monarch Initiative: MONDO:0003874

Definition

A serous adenocarcinoma that arises from the ovary and is characterized by the presence of a papillary architectural pattern. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • Ovarian serous surface papillary adenocarcinoma

Professional guidelines

PubMed

The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors.
Cathro HP, Stoler MH
Hum Pathol 2005 Feb;36(2):195-201. doi: 10.1016/j.humpath.2004.11.011. PMID: 15754297
Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW, Riopel MA, Smith Sehdev AE, Ronnett BM, Kurman RJ
Am J Surg Pathol 2002 Dec;26(12):1529-41. doi: 10.1097/00000478-200212000-00001. PMID: 12459620
Cytopathology of serous neoplasia of the ovary and the peritoneum: differential diagnosis from mesothelial proliferations.
Pisharodi LR, Bedrossian CW
Diagn Cytopathol 1996 Nov;15(4):292-5. doi: 10.1002/(SICI)1097-0339(199611)15:4<292::AID-DC8>3.0.CO;2-G. PMID: 8982583

Recent clinical studies

Etiology

Ovarian serous surface papillary borderline tumors form sea anemone-like masses.
Tanaka YO, Okada S, Satoh T, Matsumoto K, Oki A, Nishida M, Yoshikawa H, Saida T, Minami M
J Magn Reson Imaging 2011 Mar;33(3):633-40. Epub 2011 Feb 1 doi: 10.1002/jmri.22430. PMID: 21287653
Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW, Riopel MA, Smith Sehdev AE, Ronnett BM, Kurman RJ
Am J Surg Pathol 2002 Dec;26(12):1529-41. doi: 10.1097/00000478-200212000-00001. PMID: 12459620
Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal.
Prat J
Adv Anat Pathol 1999 Sep;6(5):247-74. doi: 10.1097/00125480-199909000-00002. PMID: 10472378
Normal-sized ovary carcinoma syndrome.
Feuer GA, Shevchuk M, Calanog A
Obstet Gynecol 1989 May;73(5 Pt 1):786-92. PMID: 2704507
Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma.
Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R
Am J Surg Pathol 1982 Mar;6(2):93-108. doi: 10.1097/00000478-198203000-00002. PMID: 7102898

Diagnosis

Ovarian Mesonephric-like Adenocarcinoma With Multifocal Microscopic Involvement of the Fimbrial Surface: Potential for Misdiagnosis of Tubal Intraepithelial Metastasis as Serous Tubal Intraepithelial Carcinoma Associated With Ovarian High-grade Serous Carcinoma.
Kim H, Bae GE, Jung YY, Kim HS
In Vivo 2021 Nov-Dec;35(6):3613-3622. doi: 10.21873/invivo.12667. PMID: 34697203Free PMC Article
Primary retroperitoneal serous adenocarcinoma: A case report of rare malignancy with literature review.
Win TT, Aye SN, Abdul Hamad NS, Tuan Sharif SE
Indian J Cancer 2021 Apr-Jun;58(2):262-266. doi: 10.4103/ijc.IJC_528_19. PMID: 33402586
Ultrasound diagnosis of serous surface papillary borderline ovarian tumor: A case series with a review of the literature.
Ludovisi M, Foo X, Mainenti S, Testa AC, Arora R, Jurkovic D
J Clin Ultrasound 2015 Nov-Dec;43(9):573-7. Epub 2015 Feb 23 doi: 10.1002/jcu.22266. PMID: 25706035
Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW, Riopel MA, Smith Sehdev AE, Ronnett BM, Kurman RJ
Am J Surg Pathol 2002 Dec;26(12):1529-41. doi: 10.1097/00000478-200212000-00001. PMID: 12459620
Primary neoplasia of the female peritoneum.
Fox H
Histopathology 1993 Aug;23(2):103-10. doi: 10.1111/j.1365-2559.1993.tb00467.x. PMID: 8406381

Therapy

Clinico-pathological outcomes after total parietal peritonectomy, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced serous papillary peritoneal carcinoma submitted to neoadjuvant systemic chemotherapy- largest single institute experience.
Deraco M, Sinukumar S, Salcedo-Hernández RA, Rajendra VJ, Baratti D, Guaglio M, Nizri E, Kusamura S
Eur J Surg Oncol 2019 Nov;45(11):2103-2108. Epub 2019 Jun 13 doi: 10.1016/j.ejso.2019.06.021. PMID: 31230982
Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells.
Bowen NJ, Walker LD, Matyunina LV, Logani S, Totten KA, Benigno BB, McDonald JF
BMC Med Genomics 2009 Dec 29;2:71. doi: 10.1186/1755-8794-2-71. PMID: 20040092Free PMC Article
Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
Bellone S, Siegel ER, Cocco E, Cargnelutti M, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD
Int J Gynecol Cancer 2009 Jul;19(5):860-6. doi: 10.1111/IGC.0b013e3181a8331f. PMID: 19574774
Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways.
Donninger H, Bonome T, Radonovich M, Pise-Masison CA, Brady J, Shih JH, Barrett JC, Birrer MJ
Oncogene 2004 Oct 21;23(49):8065-77. doi: 10.1038/sj.onc.1207959. PMID: 15361855
Expression of gamma-glutamyl transpeptidase in stage III and IV ovarian surface epithelial carcinomas does not alter response to primary cisplatin-based chemotherapy.
Hanigan MH, Frierson HF Jr, Taylor PT Jr
Am J Obstet Gynecol 1998 Aug;179(2):363-7. doi: 10.1016/s0002-9378(98)70365-5. PMID: 9731839

Prognosis

Primary retroperitoneal serous adenocarcinoma: A case report of rare malignancy with literature review.
Win TT, Aye SN, Abdul Hamad NS, Tuan Sharif SE
Indian J Cancer 2021 Apr-Jun;58(2):262-266. doi: 10.4103/ijc.IJC_528_19. PMID: 33402586
Ovarian serous surface papillary borderline tumors form sea anemone-like masses.
Tanaka YO, Okada S, Satoh T, Matsumoto K, Oki A, Nishida M, Yoshikawa H, Saida T, Minami M
J Magn Reson Imaging 2011 Mar;33(3):633-40. Epub 2011 Feb 1 doi: 10.1002/jmri.22430. PMID: 21287653
Borderline epithelial tumors of the ovary.
Hart WR
Mod Pathol 2005 Feb;18 Suppl 2:S33-50. doi: 10.1038/modpathol.3800307. PMID: 15761465
Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW, Riopel MA, Smith Sehdev AE, Ronnett BM, Kurman RJ
Am J Surg Pathol 2002 Dec;26(12):1529-41. doi: 10.1097/00000478-200212000-00001. PMID: 12459620
Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal.
Prat J
Adv Anat Pathol 1999 Sep;6(5):247-74. doi: 10.1097/00125480-199909000-00002. PMID: 10472378

Clinical prediction guides

Serous papillary adenocarcinoma and adult granulosa cell tumor in the same ovary. An unusual case.
Ozbey C, Erdogan G, Pestereli HE, Simsek T, Karaveli S
APMIS 2005 Oct;113(10):713-5. doi: 10.1111/j.1600-0463.2005.apm_255.x. PMID: 16309432
Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
Attanoos RL, Webb R, Dojcinov SD, Gibbs AR
Histopathology 2002 Mar;40(3):237-44. doi: 10.1046/j.1365-2559.2002.01352.x. PMID: 11895489
Serous surface papillary carcinoma. A clinicopathologic study of 10 cases and comparison with stage III-IV ovarian serous carcinoma.
Mills SE, Andersen WA, Fechner RE, Austin MB
Am J Surg Pathol 1988 Nov;12(11):827-34. PMID: 3189692
On the histogenesis and morphology of ovarian carcinomas.
Dallenbach-Hellweg G
J Cancer Res Clin Oncol 1984;107(2):71-80. doi: 10.1007/BF00399375. PMID: 6715398
Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma.
Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R
Am J Surg Pathol 1982 Mar;6(2):93-108. doi: 10.1097/00000478-198203000-00002. PMID: 7102898

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • ClinVar
      Related medical variations
    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...